NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 04:00PM ET
91.53
Dollar change
+1.45
Percentage change
1.61
%
Index- P/E- EPS (ttm)-2.04 Insider Own9.90% Shs Outstand85.13M Perf Week-3.04%
Market Cap7.79B Forward P/E77.74 EPS next Y1.18 Insider Trans-30.15% Shs Float76.73M Perf Month7.92%
Enterprise Value7.63B PEG- EPS next Q0.02 Inst Own76.31% Short Float10.97% Perf Quarter51.82%
Income-164.21M P/S65.73 EPS this Y175.26% Inst Trans17.73% Short Ratio6.03 Perf Half Y94.66%
Sales118.55M P/B34.39 EPS next Y479.40% ROA-40.26% Short Interest8.42M Perf YTD97.09%
Book/sh2.66 P/C19.41 EPS next 5Y- ROE-72.73% 52W High99.01 -7.55% Perf Year490.14%
Cash/sh4.72 P/FCF- EPS past 3/5Y-31.33% 7.21% ROIC-34.98% 52W Low15.15 504.23% Perf 3Y1943.08%
Dividend Est.- EV/EBITDA- Sales past 3/5Y1.88% - Gross Margin94.03% Volatility4.28% 3.72% Perf 5Y1708.89%
Dividend TTM- EV/Sales64.40 EPS Y/Y TTM-157.53% Oper. Margin-116.50% ATR (14)3.46 Perf 10Y-
Dividend Ex-Date- Quick Ratio8.73 Sales Y/Y TTM1131.31% Profit Margin-138.52% RSI (14)58.51 Recom1.00
Dividend Gr. 3/5Y- - Current Ratio8.86 EPS Q/Q39.61% SMA20-0.03% Beta0.12 Target Price119.17
Payout- Debt/Eq1.08 Sales Q/Q- SMA5014.46% Rel Volume0.31 Prev Close90.08
Employees209 LT Debt/Eq1.07 EarningsApr 29 BMO SMA20063.81% Avg Volume1.40M Price91.53
IPOApr 27, 2017 Option/ShortYes / Yes EPS/Sales Surpr.73.79% 42.90% Trades Volume436,265 Change1.61%
Date Action Analyst Rating Change Price Target Change
Jul-01-25Initiated Wolfe Research Outperform $170
Apr-28-25Initiated TD Cowen Buy $100
Apr-21-25Initiated Cantor Fitzgerald Overweight $80
Jan-10-25Initiated ROTH MKM Buy $68
Oct-03-24Initiated Wells Fargo Overweight $50
May-22-23Resumed Jefferies Buy $35 → $38
Sep-19-22Resumed Wedbush Outperform $27
Aug-26-22Initiated Piper Sandler Overweight $31
Sep-13-21Initiated H.C. Wainwright Buy $25
Aug-25-20Initiated Jefferies Buy $17
Jul-03-25 10:32AM
08:42AM
Jul-02-25 10:32AM
09:55AM
09:28AM
10:50AM Loading…
Jul-01-25 10:50AM
08:50AM
Jun-24-25 01:08PM
10:15AM
Jun-13-25 02:12PM
Jun-05-25 11:22AM
May-29-25 04:25PM
May-27-25 08:06PM
May-23-25 06:19AM
May-21-25 06:00AM
11:11AM Loading…
May-13-25 11:11AM
May-08-25 10:54AM
May-06-25 05:55PM
06:00AM
May-01-25 08:51AM
Apr-30-25 08:38PM
03:12AM
Apr-29-25 03:45PM
06:00AM
Apr-28-25 07:26PM
Apr-23-25 05:48PM
02:58PM
Apr-19-25 05:30AM
Apr-17-25 04:53AM
Apr-15-25 06:00AM
10:47AM Loading…
Apr-07-25 10:47AM
Mar-30-25 03:00AM
Mar-28-25 08:00AM
07:00AM
Mar-27-25 10:40PM
Mar-26-25 03:48PM
Mar-14-25 10:34AM
Mar-05-25 08:20AM
Feb-28-25 02:18AM
Feb-27-25 06:00AM
Feb-26-25 07:15AM
Feb-23-25 03:08PM
Feb-18-25 06:00AM
Feb-13-25 06:00AM
Feb-12-25 08:50AM
Jan-27-25 08:50AM
Jan-20-25 03:11PM
Jan-16-25 04:04PM
Jan-14-25 09:55AM
Jan-10-25 12:00PM
08:50AM
Jan-07-25 06:00AM
Nov-19-24 02:00AM
Nov-07-24 07:00AM
Nov-05-24 02:03AM
02:00AM
Nov-04-24 02:00AM
Nov-01-24 09:03AM
Oct-25-24 08:50AM
Oct-21-24 02:00AM
Oct-11-24 09:55AM
Oct-09-24 08:50AM
Sep-30-24 02:00AM
Sep-17-24 08:29AM
Sep-14-24 01:52AM
01:51AM
Sep-05-24 02:00AM
Aug-15-24 12:02AM
Aug-09-24 07:33AM
Aug-08-24 02:00AM
Jul-30-24 02:00AM
Jul-25-24 02:00AM
Jul-12-24 11:08AM
Jun-27-24 12:22PM
09:49AM
09:00AM
08:42AM
Jun-26-24 04:57PM
Jun-13-24 08:00AM
May-29-24 08:46AM
May-10-24 01:57PM
12:06PM
May-09-24 11:38AM
11:04AM
07:15AM
07:00AM
May-08-24 01:22PM
May-02-24 02:00AM
Apr-25-24 02:00AM
Mar-04-24 02:00AM
Mar-01-24 09:03AM
08:45AM
Feb-29-24 06:36AM
02:00AM
Feb-15-24 02:00AM
Feb-01-24 02:00AM
Jan-03-24 02:00AM
Jan-02-24 02:00AM
Dec-30-23 06:50AM
Nov-23-23 09:55AM
Verona Pharma Plc engages in the development and commercialization of therapeutics for the treatment of respiratory diseases. It focuses on developing inhaled ensifentrine for the maintenance treatment of chronic obstructive pulmonary disease. The company was founded by Michael J. A. Walker and Clive P. Page on February 24, 2005 and is headquartered in London, the United Kingdom.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Fisher AndrewGeneral CounselJun 16 '25Option Exercise2.0180,000160,904439,999Jun 18 04:31 PM
Fisher AndrewGeneral CounselJun 16 '25Sale11.5380,000922,000359,999Jun 18 04:31 PM
Hahn Mark WChief Financial OfficerJun 11 '25Sale11.40400,0004,560,36012,278,992Jun 13 04:31 PM
ZACCARDELLI DAVIDPresident and CEOJun 11 '25Sale11.40400,0004,560,52013,190,168Jun 13 04:30 PM
DAVID ZACCARDELLIDirectorJun 11 '25Proposed Sale86.7850,0004,339,000Jun 11 04:27 PM
MARK HAHNOfficerJun 11 '25Proposed Sale86.7850,0004,339,000Jun 11 04:26 PM
Hahn Mark WChief Financial OfficerMay 29 '25Sale9.33204,8641,911,66812,678,992May 29 04:16 PM
Hahn Mark WChief Financial OfficerMay 28 '25Sale9.30162,7041,513,29412,883,856May 29 04:16 PM
Hahn Mark WChief Financial OfficerMay 27 '25Sale9.5332,432308,98313,046,560May 29 04:16 PM
ZACCARDELLI DAVIDPresident and CEOMay 29 '25Sale9.33208,6961,947,59313,590,168May 29 04:15 PM
ZACCARDELLI DAVIDPresident and CEOMay 28 '25Sale9.30157,7041,466,80513,798,864May 29 04:15 PM
ZACCARDELLI DAVIDPresident and CEOMay 27 '25Sale9.5333,600320,18113,956,568May 29 04:15 PM
DAVID ZACCARDELLIDirectorMay 27 '25Proposed Sale75.0650,0003,753,000May 27 04:33 PM
MARK HAHNOfficerMay 27 '25Proposed Sale75.0650,0003,753,000May 27 04:31 PM
Sinha VikasDirectorMay 20 '25Option Exercise0.50160,00080,608234,440May 22 04:06 PM
Sinha VikasDirectorMay 20 '25Sale9.39160,0001,502,92874,440May 22 04:06 PM
VIKAS SINHADirectorMay 20 '25Proposed Sale72.5820,0001,451,600May 20 04:30 PM
Fisher AndrewGeneral CounselMay 15 '25Option Exercise2.1180,000169,040439,999May 16 04:31 PM
Fisher AndrewGeneral CounselMay 15 '25Sale8.5780,000685,600359,999May 16 04:31 PM
ACKERMANN CHRISTINADirectorMay 14 '25Option Exercise1.9340,00077,35281,880May 16 04:30 PM
ACKERMANN CHRISTINADirectorMay 14 '25Sale8.4440,000337,60041,880May 16 04:30 PM
ANDREW FISHEROfficerMay 15 '25Proposed Sale67.2430,0002,017,200May 15 04:25 PM
CHRISTINA ACKERMANNDirectorMay 14 '25Proposed Sale67.575,000337,850May 14 04:32 PM
Rickard Kathleen A.Chief Medical OfficerMay 06 '25Sale8.82114,9841,014,3432,546,472May 08 04:30 PM
KATHLEEN RICKARDOfficerMay 06 '25Proposed Sale72.2514,3731,038,449May 06 04:33 PM
Rickard Kathleen A.Chief Medical OfficerMay 01 '25Sale8.9549,200440,3502,633,320May 05 04:32 PM
Hahn Mark WChief Financial OfficerMay 02 '25Sale9.09400,0003,637,72013,078,992May 05 04:31 PM
Hahn Mark WChief Financial OfficerMay 01 '25Sale8.95187,0081,673,75913,357,728May 05 04:31 PM
EBSWORTH DAVID RDirectorMay 01 '25Option Exercise1.93140,000270,7321,476,003May 05 04:30 PM
ZACCARDELLI DAVIDPresident and CEOMay 02 '25Sale9.09400,0003,637,52013,990,168May 05 04:30 PM
ZACCARDELLI DAVIDPresident and CEOMay 01 '25Sale8.95187,0081,673,75914,268,904May 05 04:30 PM
MARK HAHNOfficerMay 02 '25Proposed Sale72.2650,0003,613,000May 02 04:24 PM
DAVID ZACCARDELLIDirectorMay 02 '25Proposed Sale72.2650,0003,613,000May 02 04:24 PM
Fisher AndrewGeneral CounselApr 29 '25Option Exercise0.0086,0640386,065May 01 08:59 PM
Fisher AndrewGeneral CounselApr 29 '25Sale8.9826,072234,127359,993May 01 08:59 PM
ZACCARDELLI DAVIDPresident and CEOApr 29 '25Option Exercise0.00229,512014,467,536May 01 08:58 PM
ZACCARDELLI DAVIDPresident and CEOApr 29 '25Sale8.9890,360811,43314,377,176May 01 08:58 PM
Rickard Kathleen A.Chief Medical OfficerApr 29 '25Option Exercise0.0086,06402,695,040May 01 08:56 PM
Rickard Kathleen A.Chief Medical OfficerApr 29 '25Sale8.9834,384308,7682,660,656May 01 08:56 PM
Hahn Mark WChief Financial OfficerApr 29 '25Option Exercise0.00229,512013,556,360May 01 08:55 PM
Hahn Mark WChief Financial OfficerApr 29 '25Sale8.9890,360811,43313,466,000May 01 08:55 PM
Sinha VikasDirectorApr 29 '25Option Exercise1.4020,00028,07689,488May 01 08:53 PM
Sinha VikasDirectorApr 29 '25Sale8.9220,000178,41674,440May 01 08:53 PM
VIKAS SINHADirectorApr 29 '25Proposed Sale68.8320,0001,376,600Apr 29 04:21 PM
Rickard Kathleen A.Chief Medical OfficerMar 12 '25Sale8.3579,264661,9422,608,976Mar 13 08:15 PM
KATHLEEN RICKARDOfficerMar 12 '25Proposed Sale62.709,908621,232Mar 12 04:23 PM
EBSWORTH DAVID RDirectorFeb 26 '25Option Exercise1.30460,000600,0601,400,003Feb 28 04:30 PM
ZACCARDELLI DAVIDPresident and CEODec 05 '24Sale5.01640,2643,205,22614,367,552Dec 06 05:51 PM
ZACCARDELLI DAVIDPresident and CEODec 06 '24Sale5.01162,800815,40014,204,752Dec 06 05:51 PM
ZACCARDELLI DAVIDPresident and CEODec 04 '24Sale5.0067,608338,16215,007,816Dec 06 05:51 PM
Hahn Mark WChief Financial OfficerDec 05 '24Sale5.01640,0483,204,14413,477,464Dec 06 05:50 PM
Hahn Mark WChief Financial OfficerDec 06 '24Sale5.01183,728920,31213,293,736Dec 06 05:50 PM
Hahn Mark WChief Financial OfficerDec 04 '24Sale5.0058,184290,99614,117,512Dec 06 05:50 PM
Hahn Mark WChief Financial OfficerNov 29 '24Sale5.0198,704494,14214,177,296Dec 02 07:20 PM
Hahn Mark WChief Financial OfficerNov 27 '24Sale5.0012,93664,68014,276,000Dec 02 07:20 PM
Hahn Mark WChief Financial OfficerDec 02 '24Sale5.001,6008,00014,175,696Dec 02 07:20 PM
ZACCARDELLI DAVIDPresident and CEONov 29 '24Sale5.0198,888495,03315,078,624Dec 02 07:19 PM
ZACCARDELLI DAVIDPresident and CEONov 27 '24Sale5.0023,240116,20015,177,512Dec 02 07:19 PM
ZACCARDELLI DAVIDPresident and CEODec 02 '24Sale5.003,20016,00015,075,424Dec 02 07:19 PM
Hahn Mark WChief Financial OfficerNov 25 '24Sale5.001,6008,00014,289,736Nov 26 06:36 PM
Hahn Mark WChief Financial OfficerNov 26 '24Sale5.008004,00014,288,936Nov 26 06:36 PM
ZACCARDELLI DAVIDPresident and CEONov 25 '24Sale5.001,6008,00015,200,752Nov 26 06:35 PM
Rickard Kathleen A.Chief Medical OfficerNov 25 '24Sale4.90240,0001,176,3602,671,480Nov 26 06:34 PM
KATHLEEN A RICKARDOfficerNov 25 '24Proposed Sale39.2130,0001,176,357Nov 25 04:42 PM
EBSWORTH DAVID RDirectorNov 18 '24Buy4.4420,00088,800940,003Nov 18 04:20 PM
ZACCARDELLI DAVIDPresident and CEONov 11 '24Sale5.002,40012,00015,202,352Nov 13 04:58 PM
Hahn Mark WChief Financial OfficerNov 11 '24Sale5.002,40012,00014,291,336Nov 13 04:57 PM
MARK HAHN OfficerNov 11 '24Proposed Sale38.58125,0004,822,500Nov 12 07:55 AM
EBSWORTH DAVID RDirectorNov 06 '24Buy4.8039,360188,881920,003Nov 07 06:57 PM
ACKERMANN CHRISTINADirectorNov 06 '24Buy4.7441,880198,38641,880Nov 07 06:56 PM
ZACCARDELLI DAVIDPresident and CEONov 04 '24Sale4.3994,144413,46215,204,752Nov 05 05:41 PM
ZACCARDELLI DAVIDPresident and CEONov 01 '24Sale4.3846,888205,19615,298,896Nov 05 05:41 PM
Hahn Mark WChief Financial OfficerNov 04 '24Sale4.3980,784354,44814,293,736Nov 05 05:40 PM
Hahn Mark WChief Financial OfficerNov 01 '24Sale4.3848,888213,93914,374,520Nov 05 05:40 PM
Hahn Mark WChief Financial OfficerOct 24 '24Sale4.38141,360618,76113,672,560Oct 25 07:55 PM
Hahn Mark WChief Financial OfficerOct 25 '24Sale4.383,20014,00013,669,360Oct 25 07:55 PM
ZACCARDELLI DAVIDPresident and CEOOct 24 '24Sale4.38140,000612,82214,596,536Oct 25 07:54 PM
ZACCARDELLI DAVIDPresident and CEOOct 25 '24Sale4.384,80021,00414,591,736Oct 25 07:54 PM
ZACCARDELLI DAVIDPresident and CEOOct 23 '24Sale4.38167014,736,536Oct 25 07:54 PM
ZACCARDELLI DAVIDPresident and CEOOct 18 '24Sale4.38245,7841,076,75515,004,920Oct 22 08:46 PM
ZACCARDELLI DAVIDPresident and CEOOct 22 '24Sale4.39157,912692,72814,736,552Oct 22 08:46 PM
ZACCARDELLI DAVIDPresident and CEOOct 21 '24Sale4.38110,456483,75314,894,464Oct 22 08:46 PM
Hahn Mark WChief Financial OfficerOct 18 '24Sale4.38249,7281,093,98314,089,960Oct 22 08:45 PM
Hahn Mark WChief Financial OfficerOct 22 '24Sale4.38159,344698,70813,813,920Oct 22 08:45 PM
Hahn Mark WChief Financial OfficerOct 21 '24Sale4.38116,696511,08213,973,264Oct 22 08:45 PM
MARK HAHN OfficerOct 18 '24Proposed Sale34.66100,0003,466,000Oct 18 04:20 PM
DAVID ZACCARDELLIDirectorOct 18 '24Proposed Sale34.66100,0003,466,000Oct 18 04:20 PM
ZACCARDELLI DAVIDPresident and CEOSep 11 '24Sale3.76600,0002,254,32015,250,704Sep 13 04:15 PM
Hahn Mark WChief Financial OfficerSep 11 '24Sale3.76600,0002,254,08014,339,688Sep 13 04:15 PM
MARK HAHN OfficerSep 11 '24Proposed Sale28.0475,0002,103,000Sep 11 04:22 PM
DAVID ZACCARDELLIDirectorSep 11 '24Proposed Sale28.0475,0002,103,000Sep 11 04:22 PM
ZACCARDELLI DAVIDPresident and CEOAug 13 '24Sale3.20398,4001,275,68115,850,704Aug 14 04:16 PM
ZACCARDELLI DAVIDPresident and CEOAug 12 '24Sale3.131,6005,00816,249,104Aug 14 04:16 PM
Hahn Mark WChief Financial OfficerAug 13 '24Sale3.20398,4001,275,54014,939,688Aug 14 04:15 PM
Hahn Mark WChief Financial OfficerAug 12 '24Sale3.131,6005,00815,338,088Aug 14 04:15 PM
EBSWORTH DAVID RDirectorAug 12 '24Buy2.8736,000103,320880,643Aug 14 04:15 PM
DAVID ZACCARDELLIOfficerAug 12 '24Proposed Sale22.6250,0001,131,000Aug 12 04:20 PM
MARK HAHN OfficerAug 12 '24Proposed Sale22.6250,0001,131,000Aug 12 04:20 PM